These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 7967500

  • 1. Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease.
    Brady RO, Murray GJ, Barton NW.
    J Inherit Metab Dis; 1994; 17(4):510-9. PubMed ID: 7967500
    [Abstract] [Full Text] [Related]

  • 2. Enzyme replacement and gene therapy for Gaucher's disease.
    Brady RO, Barton NW.
    Lipids; 1996 Mar; 31 Suppl():S137-9. PubMed ID: 8729108
    [Abstract] [Full Text] [Related]

  • 3. Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease.
    Van Patten SM, Hughes H, Huff MR, Piepenhagen PA, Waire J, Qiu H, Ganesa C, Reczek D, Ward PV, Kutzko JP, Edmunds T.
    Glycobiology; 2007 May; 17(5):467-78. PubMed ID: 17251309
    [Abstract] [Full Text] [Related]

  • 4. Molecular biology of glucocerebrosidase and the treatment of Gaucher disease.
    Barranger JA, Tomich J, Weiler S, Sakallah S, Sansieri C, Mifflin T, Bahnson A, Wei FS, Wei JF, Vallor M.
    Cytokines Mol Ther; 1995 Sep; 1(3):149-63. PubMed ID: 9384672
    [Abstract] [Full Text] [Related]

  • 5. Enzyme replacement therapy in type I Gaucher disease.
    Kay AC, Saven A, Garver P, Thurston DW, Rosenbloom BF, Beutler E.
    Trans Assoc Am Physicians; 1991 Sep; 104():258-64. PubMed ID: 1845151
    [No Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.
    Altarescu G, Schiffmann R, Parker CC, Moore DF, Kreps C, Brady RO, Barton NW.
    Blood Cells Mol Dis; 2000 Aug; 26(4):285-90. PubMed ID: 11042029
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
    Rosenthal DI, Doppelt SH, Mankin HJ, Dambrosia JM, Xavier RJ, McKusick KA, Rosen BR, Baker J, Niklason LT, Hill SC.
    Pediatrics; 1995 Oct; 96(4 Pt 1):629-37. PubMed ID: 7567322
    [Abstract] [Full Text] [Related]

  • 9. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.
    Dekker N, van Dussen L, Hollak CE, Overkleeft H, Scheij S, Ghauharali K, van Breemen MJ, Ferraz MJ, Groener JE, Maas M, Wijburg FA, Speijer D, Tylki-Szymanska A, Mistry PK, Boot RG, Aerts JM.
    Blood; 2011 Oct 20; 118(16):e118-27. PubMed ID: 21868580
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
    Pastores GM.
    Curr Opin Investig Drugs; 2010 Apr 20; 11(4):472-8. PubMed ID: 20336596
    [Abstract] [Full Text] [Related]

  • 13. Enzyme Replacement Therapy in a Gaucher Family.
    Erdem N, Buran T, Berber I, Aydogdu I.
    J Natl Med Assoc; 2018 Aug 20; 110(4):330-333. PubMed ID: 30126557
    [Abstract] [Full Text] [Related]

  • 14. Gaucher disease: a century of delineation and research. Enzyme replacement therapy: model and clinical studies.
    Beutler E, Dale GL.
    Prog Clin Biol Res; 1982 Aug 20; 95():703-16. PubMed ID: 7122644
    [Abstract] [Full Text] [Related]

  • 15. Improvement of splenomegaly and pancytopenia by enzyme replacement therapy against type 1 Gaucher disease: a report of sibling cases.
    Tsuboi K, Iida S, Kato M, Hayami Y, Hanamura I, Miura K, Harada S, Komatsu H, Banno S, Wakita A, Nitta M, Ueda R.
    Int J Hematol; 2001 Apr 20; 73(3):356-62. PubMed ID: 11345203
    [Abstract] [Full Text] [Related]

  • 16. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, Mankin HJ, Murray GJ, Parker RI, Argoff CE.
    N Engl J Med; 1991 May 23; 324(21):1464-70. PubMed ID: 2023606
    [Abstract] [Full Text] [Related]

  • 17. Enzyme replacement in Gaucher disease.
    Beutler E.
    PLoS Med; 2004 Nov 23; 1(2):e21. PubMed ID: 15578103
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM.
    Zhonghua Er Ke Za Zhi; 2006 Sep 23; 44(9):653-6. PubMed ID: 17217655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.